Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
ISIS-ANGPTL3Rx Phase 1
.
Show all posts
Showing posts with label
ISIS-ANGPTL3Rx Phase 1
.
Show all posts
Thursday, June 11, 2015
Isis Pharmaceuticals announces positive results from ISIS-ANGPTL3Rx Phase 1 study
›
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive results from a Phase 1 study with ISIS-ANGPTL3 Rx . In this study, heal...
›
Home
View web version
